Drug intelligence / Profile preview

Relief Plus

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Relief Plus is a combination oral medication used for the relief of acute pain and muscle spasms, particularly in conditions such as arthritis, spondylitis, and musculoskeletal injuries. It contains three active ingredients: - Diclofenac (a non-steroidal anti-inflammatory drug/NSAID) that reduces inflammation and pain by inhibiting prostaglandin synthesis. - Paracetamol (also known as acetaminophen), an analgesic and antipyretic that relieves pain and reduces fever. - Chlorzoxazone, a centrally acting muscle relaxant that alleviates muscle stiffness or spasm by acting on the brain and spinal cord. Together, these agents provide effective relief from musculoskeletal discomfort by reducing inflammation, blocking pain signals in the brain, and relaxing muscles[2][4].

Brand names
Relief Plus
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Relief Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relief Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call